Carter's Valuation
Is CRI * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CRI * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRI * (MX$1100) is trading above our estimate of fair value (MX$660.49)
Significantly Below Fair Value: CRI * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRI *?
Key metric: As CRI * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is CRI *'s PE Ratio? | |
---|---|
PE Ratio | 8.8x |
Earnings | US$226.07m |
Market Cap | US$1.98b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | 7.9x |
PEG Ratio | -1.4x |
Price to Earnings Ratio vs Peers
How does CRI *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 27.6x | ||
002563 Zhejiang Semir Garment | 17.3x | 14.5% | CN¥18.1b |
2232 Crystal International Group | 8.9x | 12.6% | HK$12.1b |
A081660 FILA Holdings | 23.7x | 34.3% | ₩2.4t |
3591 Wacoal Holdings | 60.4x | 25.6% | JP¥274.8b |
CRI * Carter's | 8.8x | -6.1% | Mex$2.0b |
Price-To-Earnings vs Peers: CRI * is good value based on its Price-To-Earnings Ratio (8.8x) compared to the peer average (27.5x).
Price to Earnings Ratio vs Industry
How does CRI *'s PE Ratio compare vs other companies in the Global Luxury Industry?
47 Companies | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
47 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Earnings vs Industry: CRI * is good value based on its Price-To-Earnings Ratio (8.8x) compared to the Global Luxury industry average (19.3x).
Price to Earnings Ratio vs Fair Ratio
What is CRI *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.8x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CRI *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$1,157.70 0% | 10.0% | Mex$1,337.79 | Mex$1,029.07 | n/a | 4 |
Nov ’25 | Mex$1,094.00 | Mex$1,125.90 +2.9% | 10.0% | Mex$1,301.04 | Mex$1,000.80 | n/a | 4 |
Oct ’25 | n/a | Mex$1,156.96 0% | 11.8% | Mex$1,432.12 | Mex$994.53 | n/a | 6 |
Sep ’25 | n/a | Mex$1,053.19 0% | 6.2% | Mex$1,125.07 | Mex$937.56 | n/a | 6 |
Aug ’25 | n/a | Mex$1,053.19 0% | 6.2% | Mex$1,125.07 | Mex$937.56 | n/a | 6 |
Jul ’25 | n/a | Mex$1,186.75 0% | 9.2% | Mex$1,359.53 | Mex$1,019.65 | n/a | 6 |
Jun ’25 | n/a | Mex$1,186.75 0% | 9.2% | Mex$1,359.53 | Mex$1,019.65 | n/a | 6 |
May ’25 | n/a | Mex$1,215.96 0% | 10.0% | Mex$1,380.32 | Mex$1,021.20 | n/a | 7 |
Apr ’25 | n/a | Mex$1,273.82 0% | 9.0% | Mex$1,402.05 | Mex$1,111.38 | n/a | 6 |
Mar ’25 | n/a | Mex$1,273.82 0% | 9.0% | Mex$1,402.05 | Mex$1,111.38 | n/a | 6 |
Feb ’25 | n/a | Mex$1,186.08 0% | 10.3% | Mex$1,417.51 | Mex$1,012.51 | n/a | 7 |
Jan ’25 | n/a | Mex$1,238.90 0% | 10.9% | Mex$1,514.50 | Mex$1,081.79 | n/a | 7 |
Dec ’24 | n/a | Mex$1,238.90 0% | 10.9% | Mex$1,514.50 | Mex$1,081.79 | n/a | 7 |
Nov ’24 | n/a | Mex$1,238.90 0% | 10.9% | Mex$1,514.50 | Mex$1,081.79 | Mex$1,094.00 | 7 |
Oct ’24 | n/a | Mex$1,174.50 0% | 9.5% | Mex$1,406.53 | Mex$1,038.15 | n/a | 7 |
Sep ’24 | n/a | Mex$1,174.50 0% | 9.5% | Mex$1,406.53 | Mex$1,038.15 | n/a | 7 |
Aug ’24 | n/a | Mex$1,174.50 0% | 9.5% | Mex$1,406.53 | Mex$1,038.15 | n/a | 7 |
Jul ’24 | n/a | Mex$1,227.23 0% | 11.0% | Mex$1,509.65 | Mex$1,078.32 | n/a | 7 |
Jun ’24 | n/a | Mex$1,227.23 0% | 11.0% | Mex$1,509.65 | Mex$1,078.32 | n/a | 7 |
May ’24 | n/a | Mex$1,232.91 0% | 10.5% | Mex$1,510.31 | Mex$1,114.75 | n/a | 7 |
Apr ’24 | n/a | Mex$1,241.08 0% | 10.5% | Mex$1,520.32 | Mex$1,122.14 | n/a | 7 |
Mar ’24 | Mex$2,025.50 | Mex$1,283.70 -36.6% | 10.4% | Mex$1,543.59 | Mex$1,139.32 | n/a | 7 |
Feb ’24 | Mex$2,025.50 | Mex$1,367.51 -32.5% | 11.0% | Mex$1,624.43 | Mex$1,198.99 | n/a | 7 |
Jan ’24 | Mex$2,025.50 | Mex$1,386.31 -31.6% | 11.4% | Mex$1,633.56 | Mex$1,205.73 | n/a | 7 |
Dec ’23 | Mex$2,025.50 | Mex$1,386.31 -31.6% | 11.4% | Mex$1,633.56 | Mex$1,205.73 | n/a | 7 |
Nov ’23 | Mex$2,025.50 | Mex$1,457.77 -28.0% | 17.0% | Mex$1,981.44 | Mex$1,228.49 | n/a | 7 |
Analyst Forecast: Target price is less than 20% higher than the current share price.